Molbio Diagnostics has joined forces with the Global Fund, USAID, and the Stop TB Partnership to make rapid tuberculosis (TB) testing more accessible worldwide. Through this collaboration, countries can now procure Molbio’s WHO-endorsed Truenat platform at internationally negotiated, lower prices, boosting access to high-quality diagnostics in remote and underserved regions. The Truenat system, capable of detecting over 40 diseases, will play a key role in the global effort to end TB by 2030 by enabling fast, affordable, and decentralized testing.
